LSX World Congress

STRATEGY, INVESTMENT, PARTNERING & COMMERCIALISATION FOR LIFE SCIENCE EXECUTIVE LEADERS

 

7th Annual



1-5 February 2021
Delivered Virtually

#lsxworld
@lsxleaders

Created by    LSX

DOWNLOAD BROCHURE

REGISTER NOW

LSX World Congress Virtual


For 6 years, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science strategy, investment, partnering and deal making.

LSX World Congress gathers the founders and CEOs of innovative start-ups through to publicly listed life sciences giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.

The industry’s c-suite will be joined by the sector’s most active investors, pharma and health tech BD&L teams, R&D leaders, KOLs and top tier service companies who are moving the sector forward.

In an industry as dynamic as the life science and healthcare sector, LSX World Congress brings the people who are tackling the biggest challenges in the industry today, and helps answer the question; where to next and how do we get there?

With our relentless focus on quality peer-to-peer discussion, high-level networking and partnering, intimate conference formats and a vetted, high-calibre audience, we help you Connect with Purpose.

In 2021, the event will be a virtual experience incorporating all the same features of the usual physical meeting, but spread across a full week. The event also welcomes Healthtech Leaders underneath the LSX World Congress banner, joining Biotech Leaders and Medtech Leaders.

LSX World Congress

The premier conference for leaders in life sciences investment, technology, business and strategy

Week at a Glance


Monday
1 February


LSX IPO Bootcamp


Full details coming soon

Tuesday
2 February

Biotech Leaders

Capital Markets & Investment

HealthTech Leaders

Life Science & Digital Health Partnerships

Medtech Leaders

Design, Development & Digitisation

Wednesday
3 February

Biotech Leaders

Partnerships & Deal-Making

HealthTech Leaders

Capital Markets & Investment

Medtech Leaders

Capital Markets & Investment

Thursday
4 February

Biotech Leaders

Capital Deployment & Commercialisation Strategy

HealthTech Leaders

Payers, Providers & Reimbursement

Medtech Leaders

Market Access & Commercialisation Strategy

Friday
5 February


1:1 Partnering



1:1 Partnering (24 hours all week)

Early Confirmed Speakers (Lots more to come!)


Adrian Cassidy, Global Head of Real-World Evidence, Novartis

Adrian Cassidy

Global Head of Real-World Evidence
Novartis
Maria Dahl, COO and Head of Europe, Innovent Bio

Maria Dahl

COO and Head of Europe
Innovent Bio
Didier Deltort, President, Europe, Middle East and Africa, Zimmer Biomet

Didier Deltort

President, Europe, Middle East and Africa
Zimmer Biomet
Jennifer Esposito, VP Health, Magic Leap

Jennifer Esposito

VP Health
Magic Leap
Jessica Federer, Partner, Boston Millennia Partners

Jessica Federer

Partner
Boston Millennia Partners
Doug Giordano, SVP Worldwide BD, Pfizer

Doug Giordano

SVP Worldwide BD
Pfizer
Michael Greeley, General Partner, Flare Capital

Michael Greeley

General Partner
Flare Capital
Abraham Heifets, Co-Founder & CEO, Atomwise

Abraham Heifets

Co-Founder & CEO
Atomwise
Lara Koole, Partner, Philips Ventures, Philips

Lara Koole

Partner, Philips Ventures
Philips
Rana Lonnen, Head Search and Evaluation Strategic Venture Capital, ‎Novartis

Rana Lonnen

Head Search and Evaluation Strategic Venture Capital
Novartis
Sean Marrett, CBO, BioNTech

Sean Marrett

CBO
BioNTech
Elizabeth Mily, EVP BD, Bristol Myers Squibb

Elizabeth Mily

EVP BD
Bristol Myers Squibb
Vivek Ramaswamy, CEO, Roivant Sciences

Vivek Ramaswamy

CEO
Roivant Sciences
Aradhana Sarin, CFO, Alexion Pharmaceuticals

Aradhana Sarin

CFO
Alexion Pharmaceuticals
Ben Thorner, SVP and Head MRL Business Development & Licensing, Merck & Co

Ben Thorner

SVP & Head MRL Business Development & Licensing
Merck & Co
Christian Weiß, Managing Partner, Heal Capital

Christian Weiß

Managing Partner
Heal Capital

2020 Key Stats


1000+

REGISTERED
ATTENDEES

30%

INVESTORS

750+

UNIQUE
COMPANIES

45%

LIFE SCIENCE
COMPANIES

250+

UNIQUE INVESTMENT
FIRMS

2000+

ONSITE
MEETINGS

Platinum Partners


Nasdaq 300x150

Gold Partners


Beigene 300x150
Bird & Bird 300x150

Cello Health Bioconsulting 300x150

Cello Health Consulting
citi 300x150

Deloitte
DFIN Solutions
freshfields
Goodwin 300x150

Guided Solutions
Latham & Watkins 300x
Medtronic 300x150
MSD Inventing For Life
NDA Group
Potter Clarkson
Premier Research 300x150
SVB Leerink 300x150


Knowledge Partner


McKinsey and company

Silver Partners


Fish & Richardson 300x

Kempen 300x-1

MAVIE Technologies

MCRA 300x

DOWNLOAD BROCHURE